A Medical Device Daily
Bruker Daltonics NBC Detection (Billerica, Massachusetts) reported receiving a $750,000 follow-on Phase II contract award from the U.S. Department of Homeland Security for further research and development into the Autonomous Rapid Facility Chemical Agent Monitor (ARFCAM).
ARFCAM is intended to be the next generation chemical agent monitor for government facilities.
Frank Thibodeau, vice president for NBC business development, said that the award indicates that Bruker Daltonics “has performed well in Phase I and has unique expertise to design and deliver the next-generation technology to help protect our country from the threat of chemical terrorism. This is a challenging program with accelerated timelines and ambitious technical specifications.”
Bruker BioSciences is the parent company of Bruker Daltonics and Bruker AXS. Bruker Daltonics provides life science tools based on mass spectrometry develops nuclear, biological and chemical detection systems. Bruker AXS is a provider of life science and advanced materials research tools based on X-ray technology.